Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 3, 2011, Pages 205-211

  Contini, Verônica ^a   Victor, Marcelo M ^b   Cerqueira, Caio C S ^a   Polina, Evelise R ^a   Grevet, Eugênio H ^b   Salgado, Carlos A I ^b   Karam, Rafael G ^b   Vitola, Eduardo S ^b   Belmonte De Abreu, Paulo ^a,b   Bau, Claiton H D ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

ADRA2A gene; Attention deficit hyperactivity disorder; Methylphenidate; Pharmacogenetics

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; METHYLPHENIDATE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-2; YOUNG ADULT;

EID: 79958720815     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-010-0172-4     Document Type: Article

References (59)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2. Arnsten AF, Dudley AG (2005) Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 1(1):2
3. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57(11):1377-1384 (Pubitemid 40798558)
4. Arnsten AF (2009) Toward a new understanding of attentiondeficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23(Suppl 1):33-41
5. Barkley RA (1990) Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Guilford Press, New York
6. Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65(Suppl 3):3-7
7. Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237-248 (Pubitemid 40981053)
8. Brown RT, Amler RW, Freeman WS et al (2005) Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115(6):e749-e757 (Pubitemid 43843150)
9. Charach A, Ickowicz A, Schachar R (2004) Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43(5):559-567 (Pubitemid 38812367)
10. Cheon KA, Cho DY, Koo MS et al (2009) Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder. Biol Psychiatry 65(7):564-570
11. Contini V, Victor MM, Marques FZ et al (2010) Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD. J Neural Transm 117(2):269-276
12. da Silva TL, Pianca TG, Roman T et al (2008) Adrenergic alphα2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type. J Neural Transm 115(2):341-345
13. de Cerqueira CCS, Polina ER, Contini V et al (2010) ADRA2A polymorphisms and ADHD in adults: possible mediating effect of personality. Psychiatry Res. doi:10.1016/j.psychres.2010.08.032
14. Faraone SV, Biederman J, Weber W et al (1998) Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 37(2):185-193 (Pubitemid 28099186)
15. Faraone SV, Spencer T, Aleardi M et al (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attentiondeficit/hyperactivity disorder. J Clin Psychopharmacol 24(1): 24-29 (Pubitemid 38134162)
16. Fischer AG, Bau CHD, Grevet EH et al (2007) The role of comorbid major depressive disorder in the clinical presentation of adult ADHD. J Psychiatr Res 41:991-996
17. Froehlich TE, McGough JJ, Stein MA (2010) Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs 24(2):99-117
18. Gaub M, Carlson CL (1997) Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 36(8):1036-1045 (Pubitemid 27337654)
19. Gizer IR, Ficks C, Waldman ID (2009) Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126(1):51-90
20. Greenhill L, Beyer DH, Finkleson J et al (2002) Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/hyperactivity disorder. J Atten Disord 6(Suppl 1):S89-100
21. Grevet EH, Bau CHD, Salgado CA et al (2005) Interrater reliability for diagnosis in adults of attention deficit hyperactivity disorder and oppositional defiant disorder using K-SADS-E. Arq Neuropsiquiatr 63:307-310 (Pubitemid 40834728)
22. Grevet EH, Bau CHD, Salgado CA et al (2006) Lack of gender effects on subtype outcomes in adults with attention-deficit/hyperactivity disorder: support for the validity of subtypes. Eur Arch Psychiatry Clin Neurosci 256:311-319 (Pubitemid 44285056)
23. Guy W (1976) ECDU Assessment manual for psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education and Welfare
24. Heal DJ, Cheetham SC, Smith SL (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57(7-8):608-618
25. Kalil KL, Bau CH, Grevet EH et al (2008) Smoking is associated with lower performance in WAIS-R Block Design scores in adults with ADHD. Nicotine Tob Res 10(4):683-688 (Pubitemid 351566554)
26. Karam RG, Bau CH, Salgado CA et al (2009) Late-onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res 43(7):697-701
27. Kieling C, Genro JP, Hutz MH, Rohde LA (2010) A current update on ADHD pharmacogenomics. Pharmacogenomics 11(3):407-419
28. Kolar D, Keller A, Golfinopoulos M et al (2008) Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat 4(1):107-121 (Pubitemid 351467380)
29. Kooij JJ, Burger H, Boonstra AM et al (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 34(6):973-982
30. Kurnik D, Muszkat M, Li C et al (2006) Variations in the alphα2A-adrenergic receptor gene and their functional effects. Clin Pharmacol Ther 79(3):173-185
31. Lahiri DK, Nurnberger JI Jr (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 11:5444
32. Lario S, Calls J, Cases A et al (1997) MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet 51(2):129-130 (Pubitemid 27149724)
33. Lee HY, Kang RH, Paik JW et al (2009) Association of the adrenergic alpha 2a receptor-1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder. Brain Res 1262:1-6
34. Lima JJ, Feng H, Duckworth L et al (2007) Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 56(6):757-765 (Pubitemid 46734082)
35. Long JC, Williams RC, Urbanek M (1995) An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet 56:799-810
36. Long JC (1999) Multiple locus haplotype analysis, version 3.0. Software and documentation distributed by the author. Department of Human Genetics, University of Michigan Medical School, 4909 Buhl Bldg., Ann Arbor, MI 4819-0618
37. Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138(11):923-936 (Pubitemid 24002359)
38. Mick E, Neale B, Middleton FA et al (2008) Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/ hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B(8):1412-1418
39. Murphy K, Barkley RA (1996) Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 37(6):393-401 (Pubitemid 26383062)
40. Park YC, Chung SH, Lee KJ et al (2006) Weight gain associated with the alphα2A-adrenergic receptor-1, 291 C/G polymorphism and olanzapine treatment. Am J Med Genet B Neuropsychiatr Genet 141:394-397
41. Park L, Nigg JT, Waldman ID et al (2005) Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10(6):572-580 (Pubitemid 40897041)
42. Polanczyk G, de Lima MS, Horta BL et al (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942-948 (Pubitemid 46972911)
43. Polanczyk G, Zeni C, Genro JP et al (2007) Association of the adrenergic alphα2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64(2):218-224 (Pubitemid 46220779)
44. Prestes AP, Marques FZ, Hutz MH et al (2007) Tobacco smoking and the ADRA2A C-1291G polymorphism. J Neural Transm 114(11):1503-1506 (Pubitemid 350112286)
45. Prince J (2008) Catecholamine dysfunction in attention-deficit/ hyperactivity disorder: an update. J Clin Psychopharmacol 28(3 Suppl 2):S39-S45
46. Roman T, Polanczyk GV, Zeni C et al (2006) Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol Psychiatry 11(1):8-10 (Pubitemid 43251082)
47. Roman T, Schmitz M, Polanczyk GV et al (2003) Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attentiondeficit/hyperactivity disorder? Am J Med Genet B Neuropsychiatr Genet 120(1):116-120 (Pubitemid 37059387)
48. Rösler M, Fischer R, Ammer R et al (2009) A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259(2):120-129
49. Schmitz M, Denardin D, Silva TL et al (2006) Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry 60(10):1028-1033 (Pubitemid 44647211)
50. Simon V, Czobor P, Bálint S et al (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194(3):204-211
51. Spencer T, Biederman J, Wilens T et al (2005) A large, doubleblind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57(5):456-463 (Pubitemid 40311979)
52. Spencer J, Biederman T, Wilens M et al (1996) Pharmacotherapy of attention deficit hyperactivity disorder across the lifespan. J Am Acad Child Adolesc Psychiatry 35:409-428
53. Staddon S, Arranz MJ, Mancama D et al (2002) Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology 162(1):18-23 (Pubitemid 34639551)
54. Swanson JM (1992) School-based assessments and interventions for ADD students. KC Publishing, Irvine
55. Tamam L, Karakus G, Ozpoyraz N (2008) Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 258(7):385-393
56. Victor MM, Grevet EH, Salgado CA et al (2009) Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/ hyperactivity disorder: the role of comorbidities. J Clin Psychopharmacol 29(6):614-616
57. Wakeno M, Kato M, Okugawa G et al (2008) The alpha 2Aadrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran. J Clin Psychopharmacol 28(5):518-524
58. Wechsler D (1981) WAIS-R-manual for the wechsler adult intelligence scale-revised. The Psychological Corporation, San Antonio, Texas
59. Wilens TE (2008) Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28(3 Suppl 2):S46-S53